"Die Augenklinik ist eine Klinik der Maximalversorgung und eine der größten Augenkliniken in Europa Es werden Patienten in 19 Spezialambulanzen in allen Bereichen der Augenheilkunde behandelt und das gesamte Leistungsspektrum der Augenheilkunde abgebildet. Außerhalb der regulären Öffnungszeiten besteht eine Notfallversorgung, die auch eine 24-stündige OP Bereitschaft umfasst."

During the past decade, LMU Klinikum der Universität, Augenklinik conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LMU Klinikum der Universität, Augenklinik" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Implandata Ophthalmic Products GmbH" with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored and "STZ eyetrial" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LMU Klinikum der Universität, Augenklinik" #1 collaborator was "CRO Dr. med. Kottmann GmbH & Co. KG" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "University Hospital Tuebingen" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "LMU Klinikum der Universität, Augenklinik" are "Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Glaucoma" (2 trials), "Open Angle Glaucoma" (2 trials) and "Exudative Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "LMU Klinikum der Universität, Augenklinik" in a lesser frequency.

Most popular intervention types in "LMU Klinikum der Universität, Augenklinik" are "Drug" (10 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "ARGOS-SC suprachoroidal pressure sensor" (2 trials), "Faricimab" (2 trials), "Lampalizumab" (2 trials) and "APL-2" (1 trials). Other intervention names were less common.

The vast majority of trials in "LMU Klinikum der Universität, Augenklinik" are 12 trials for "All" genders.

Currently, there are NaN active trials in "LMU Klinikum der Universität, Augenklinik". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in LMU Klinikum der Universität, Augenklinik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in LMU Klinikum der Universität, Augenklinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".